- Country: USA
- Summary: Nei Regenerative Medicine Clinical Trial Planning Grant (R34 - Clinical Trials not Allowed)
- UST Ref No: 59977816
- Deadline: 07 Jan 2025
- Financier: Self Financed
- Purchaser Ownership: Government
- Tender Value: Refer Document
- Notice Type: Tender
- Document Ref. No.: PAR-22-070
- Purchaser's Detail:Login to see full purchaser details. Login to see full purchaser details. Login to see full purchaser details. Login to see full purchaser details. Login to see full purchaser details. Login to see full purchaser details. Login to see full purchaser details. Login to see full purchaser details. Login to see full purchaser details.
- Description:
- Tender are invited for NEI Regenerative Medicine Clinical Trial Planning Grant (R34 - Clinical Trials Not Allowed)
CFDA Number : 93.867 -- Vision Research
Cost Sharing or Matching Requirement : No
Closing Date for Applications: Jan 07, 2025
Posted Date : Nov 16, 2021
Description: The National Eye Institute (NEI) Audacious Goal Initiative (AGI) is an effort to push the boundaries of vision science and restore vision through regeneration of cells in the retina. AGI research specifically targets photoreceptors (PRCs) and retinal ganglion cells (RGCs) in the eye. Photoreceptors often called rods and cones are cells in the retina that, when stimulated by light, generate signals the brain perceives as images. The retinal ganglion cells carry these signals from the photoreceptors to the brain. Although there has been some success in regenerating retinal neurons and connections in fish, mice, and other systems, the ultimate goal of the AGI is to restore vision in humans. - Documents:
If you are registered member, kindly login to view full details of this tender notice:
CLICK HERE TO LOGINNei Regenerative Medicine Clinical Trial Planning Grant (R34 - Clinical Trials not Allowed) - USA Tender
The NATIONAL INSTITUTES OF HEALTH, a Government sector organization in USA, has announced a new tender for Nei Regenerative Medicine Clinical Trial Planning Grant (R34 - Clinical Trials not Allowed). This tender is published on USARFP under UST Ref No: 59977816 and is categorized as a Tender. Interested and eligible suppliers are invited to participate by reviewing the tender documents and submitting their bids before the deadline on 2025-01-07.
The estimated tender value is Refer Document, and full details, including technical specifications and submission requirements, are provided in the official tender documents. Ensure all submissions meet the criteria outlined to be considered for evaluation.
